Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
2086689-07-6 | Azido-PEG3-methyl ester | AA019E8K | MFCD30723268
2144777-92-2 | Azido-PEG5-CH2CO2-PFP | AA019EDK | MFCD31561140
2183440-77-7 | Cy5.5 bis-NHS ester | AA019EH8 | MFCD31615444
1250883-57-8 | Racemic-(3aR,4S,6S,7S,7aS)-5-tert-butyl 6-ethyl 2,2-dimethyltetrahydro-4,7-methano[1,3]dioxolo[4,5-c]pyridine-5,6(6H)-dicarboxylate | AA019EKD | MFCD28390377
1094679-27-2 | 4-Ethynylpyridin-2-amine | AA019ENI | MFCD13189750
349404-95-1 | 4-bromo-N-(4-ethylphenyl)benzenesulfonamide | AA019EQK | MFCD01215104
543741-43-1 | 2-(2-(4-Fluorobenzyl)phenyl)acetic acid | AA019ETS | MFCD28387783
1797976-77-2 | 1-oxa-2,8-diazaspiro[4.5]dec-2-ene-3-carboxylic acid hydrochloride | AA019EX3 | MFCD26593751
55985-32-5 | Nicardipine | AA019FPG | MFCD00216027
1378818-99-5 | 6-Methylthiazolo[4,5-b]pyridin-2-amine | AA019FWX | MFCD14581832
